Breakdown | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|---|
Income Statement | |||||
Total Revenue | 19.40B | 18.90B | 17.82B | 15.36B | 13.06B |
Gross Profit | 3.77B | 3.93B | 3.12B | 2.64B | 1.72B |
EBITDA | 4.21B | 3.42B | 2.34B | 2.19B | 1.26B |
Net Income | 2.18B | 1.66B | 745.00M | 1.19B | 132.78M |
Balance Sheet | |||||
Total Assets | 19.22B | 17.76B | 16.85B | 15.55B | 14.25B |
Cash, Cash Equivalents and Short-Term Investments | 4.19B | 3.90B | 2.53B | 1.85B | 1.40B |
Total Debt | 1.45B | 1.95B | 2.50B | 2.53B | 2.95B |
Total Liabilities | 5.06B | 5.45B | 6.10B | 5.39B | 5.20B |
Stockholders Equity | 14.15B | 12.32B | 10.75B | 10.15B | 9.05B |
Cash Flow | |||||
Free Cash Flow | 1.09B | 2.13B | 588.00M | 986.23M | -277.61M |
Operating Cash Flow | 3.22B | 3.38B | 2.52B | 1.84B | 635.35M |
Investing Cash Flow | -2.26B | -1.28B | -1.82B | -784.90M | -905.44M |
Financing Cash Flow | -663.00M | -722.00M | -19.00M | -961.10M | -532.23M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
81 Outperform | ¥20.71B | 4.45 | 2.57% | 5.07% | 24.88% | ||
79 Outperform | ¥13.42B | 6.17 | 4.41% | 2.62% | 31.70% | ||
75 Outperform | ¥155.42B | 6.63 | 10.52% | 3.58% | 4.65% | 11.70% | |
70 Outperform | ¥28.96B | 20.37 | 0.85% | -0.54% | -13.51% | ||
68 Neutral | ¥197.01B | 21.38 | 8.29% | 2.28% | 4.93% | 0.72% | |
66 Neutral | ¥55.39B | 25.39 | 1.09% | 13.62% | 24.54% | ||
63 Neutral | ¥61.48B | 15.21 | 2.30% | 1.11% | ― |